+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Importance of C-6 chirality in conferring irreversible opioid antagonism to naltrexone-derived affinity labels

Importance of C-6 chirality in conferring irreversible opioid antagonism to naltrexone-derived affinity labels

Journal of Medicinal Chemistry 26(9): 1229-1235

A series of five epimeric pairs of naltrexone derivatives that contain an electrophilic substituent at the 6 alpha- or 6 beta-position was synthesized and tested on the guinea pig ileal longitudinal muscle (GPI) and mouse vas deferens (MVD) preparations in order to determine if the orientation of the electrophile is important for covalent bonding to opioid receptors. In the GPI all compounds were pharmacologically active as reversible agonists, but only the 6 beta-isomers of the fumaramate ester 2b (beta-FNA) and isothiocyanate 6b exhibited covalent reactivity, involving a selective irreversible antagonism of the mu agonist, morphine, without affecting kappa agonists. The 6 alpha-isomer 2a (alpha-FNA) was itself nonalkylating but was able to protect the GPI against alkylation by its epimer, beta-FNA, indicating that the two epimers bind to the same receptor. These results suggest that the proper orientation of the electrophilic substituent is required for covalent bonding with a proximal nucleophile in the case of mu receptor blockade. Moreover, the lack of covalent bonding to kappa receptors by these or other ligands in this series indicates the possible absence of sufficiently reactive nucleophiles on this recognition site. In the MVD, 2b, but not 2a, irreversibly antagonized morphine (as in GPI), whereas neither epimer exhibited irreversible antagonism toward the delta agonist, [D-Ala2,D-Leu5]enkephalin (DADLE). In contrast, both of the isothiocyanate epimers (6a,b) irreversibly blocked mu and delta receptors. Evidence suggesting differences between mu receptors in the MVD and GPI was obtained with the beta-iodoacetamide 5b, which was an irreversible blocker of morphine only in the MVD. When analyzed together with those of previous studies with the nitrogen mustard analogues, alpha- and beta-chlornaltrexamine, the data suggest that the receptor-alkylating ability of each isomer in an epimeric pair differs most when the electrophile possesses a narrow spectrum of reactivity.

(PDF emailed within 1 workday: $29.90)

Accession: 043346942

Download citation: RISBibTeXText

PMID: 6310111

Related references

Importance of carbon 6 chirality in conferring irreversible opioid antagonism to naltrexone derived affinity labels. Journal of Medicinal Chemistry 26(9): 1229-1235, 1983

Design and synthesis of naltrexone derived affinity labels with nonequilibrium opioid agonist and antagonist activities evidence for the existence of different mu receptor subtypes in different tissues. Journal of Medicinal Chemistry 27(10): 1325-1335, 1984

Application of the message-address concept to the docking of naltrexone and selective naltrexone-derived opioid antagonists into opioid receptor models. Neurochemical Research. 21(11): 1287-1294, 1996

Opioid antagonist activity of naltrexone-derived bivalent ligands: importance of a properly oriented molecular scaffold to guide "address" recognition at kappa opioid receptors. Journal of Medicinal Chemistry 39(9): 1816-1822, 1996

Irreversible inhibition of the bacterial cysteine protease-transpeptidase sortase (SrtA) by substrate-derived affinity labels. Biochemical Journal 366(Pt 3): 953-958, 2002

Reporter affinity labels derived from a 14beta-amino isosteric analog of naltrindole as selective delta-opioid receptor antagonists. Abstracts of Papers American Chemical Society 224(1-2): MEDI 241, 2002

Diastereomeric 6 deoxy 6 spiro alpha methylene gamma butyrolactone derivatives of naltrexone and oxymorphone selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand. Journal of Medicinal Chemistry 27(12): 1718-1723, 1984

Nontolerance to the opioid antagonism of naltrexone. Biological Psychiatry 20(1): 66-72, 1985

A photoactivatable naltrexone derivative labels glycoproteins of different molecular weight corresponding to the m- and k-opioid receptors. Biochemistry (American Chemical Society) 31: 85-93, 1992

Discovery of dermorphin-based affinity labels with subnanomolar affinity for mu opioid receptors. Journal of Medicinal Chemistry 52(23): 7372-7375, 2010

A photoactivatable naltrexone derivative labels glycoproteins of different molecular weight corresponding to the mu- and kappa-opioid receptors. Biochemistry. 31(40): 9685-9693, 1992

The synthesis of DAMGO-based potential affinity labels with high mu opioid receptor affinity and the formation of cyclic O-alkyl thiocarbamates. Advances in Experimental Medicine and Biology 611: 265-266, 2009